PATENT CLAIM ANALYSIS

Application Number: 15879130
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2018-05
Patent Classification: ["548", "309700"]

Abstract:
The present invention is directed to bendamustine esters and bendamustine amides and their use for the treatment of cancer.

Claim (Index 18):
The method according to  claim 17 , wherein said cancer is in the form of a solid tumor.

Metadata:
- Claim Count in Document: 51.0
- Percentile: 86.0
- Lexical Diversity: 1.11111
- Patent Class: 548.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15456439', '14442088', '15184968', '14711747', '14699965']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7913270435077485
- 35 USC 102 Novelty (BERT): 0.5403556156526148
- Combined Prediction Score: 0.7662299007222352
- Mean Citation Score: 360.282652
- Max Citation Score: 380.62274
- Similarity Product: 342.067176023587

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test